Cm. Coffin et al., INFLAMMATORY MYOFIBROBLASTIC TUMOR, INFLAMMATORY FIBROSARCOMA, AND RELATED LESIONS - AN HISTORICAL REVIEW WITH DIFFERENTIAL DIAGNOSTIC CONSIDERATIONS, Seminars in diagnostic pathology, 15(2), 1998, pp. 102-110
The concept of the inflammatory myofibroblastic tumor (IMT) has evolve
d from an already perplexing pathological process, the inflammatory ps
eudotumor, which was initially recognized in the lung and regarded as
a pseudoneoplasm, although its histological features resembled a spind
le cell sarcoma. Despite the pathological findings and their apparent
prognostic implications, most affected individuals regardless of the p
rimary site have had favorable clinical outcomes. The designation of i
nflammatory pseudotumor came to be widely accepted, although these les
ions were clearly tumors or masses that may or may not have been pseud
oneoplasms. An aberrant or exaggerated response to tissue injury witho
ut an established cause has generally been favored as the pathogenesis
of the inflammatory pseudotumor or IMT. Once the myofibroblast was id
entified and its function in tissue repair was established, this cell
type was found in a variety of soft tissue lesions from nodular fascii
tis to malignant fibrous histiocytoma. The myofibroblast was eventuall
y recognized as the principal cell type in the inflammatory pseudotumo
r, which provided the opportunity to redesignate this tumor as IMT. So
me of the clinical and pathological aspects of the IMT began to sugges
t the possibility that these lesions are more similar to neoplasms tha
n a postinflammatory process. Another step in the evolution of the inf
lammatory pseudotumor and IMT occurred with the report of a mesenteric
or retroperitoneal tumor with similar pathological features to the la
tter tumors but with more aggressive behavior to warrant an interpreta
tion of malignancy as an inflammatory fibrosarcoma. The IMT and inflam
matory fibrosarcoma appear to have many overlapping clinical and patho
logical features. These tumors are histogenetically related, and if th
ey are separate entities, they are differentiated more by degrees than
absolutes. The therapeutic approach to these tumors should relay prim
arily on surgical resection, Studies in the future may possibly resolv
e the question whether the IMT and inflammatory fibrosarcoma are synon
ymous or closely related entities. Copyright (C) 1998 by W.B. Saunders
Company.